Candriam SCA’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128M Buy
309,295
+76,456
+33% +$28.3M 0.58% 34
2026
Q1
$63M Sell
232,839
-6,226
-3% -$1.85M 0.33% 66
2025
Q4
$78.9M Buy
239,065
+5,793
+2% +$1.96M 0.39% 54
2025
Q3
$80.5M Buy
233,272
+38,075
+20% +$11.5M 0.42% 50
2025
Q2
$60.9M Sell
195,197
-96,561
-33% -$36.9M 0.35% 72
2025
Q1
$153M Sell
291,758
-87,423
-23% -$44.7M 0.96% 21
2024
Q4
$192M Sell
379,181
-115,757
-23% -$65.8M 1.1% 14
2024
Q3
$289M Buy
494,938
+44,572
+10% +$25.2M 1.66% 7
2024
Q2
$229M Buy
450,366
+58,014
+15% +$28.4M 1.39% 9
2024
Q1
$194M Sell
392,352
-48,196
-11% -$24.5M 1.24% 12
2023
Q4
$232M Buy
440,548
+3,851
+0.9% +$2.05M 1.6% 7
2023
Q3
$111K Sell
436,697
-45,129
-9% -$22.2M ﹤0.01% 655
2023
Q2
$232M Sell
481,826
-54,658
-10% -$26.7M 1.67% 6
2023
Q1
$233M Buy
536,484
+44,209
+9% +$21.3M 1.62% 7
2022
Q4
$261M Buy
492,275
+8,357
+2% +$4.43M 1.76% 6
2022
Q3
$244M Buy
483,918
+94,462
+24% +$49.7M 1.72% 6
2022
Q2
$200M Buy
389,456
+33,073
+9% +$16.6M 1.65% 10
2022
Q1
$182M Buy
356,383
+15,092
+4% +$7.28M 1.24% 10
2021
Q4
$171M Sell
341,291
-20,869
-6% -$9.45M 1.09% 10
2021
Q3
$142M Buy
362,160
+18,867
+5% +$7.81M 0.96% 13
2021
Q2
$137M Buy
343,293
+179,390
+109% +$71.5M 0.94% 12
2021
Q1
$56.2M Buy
163,903
+4
+0% +$1.39K 0.47% 44
2020
Q4
$58.5M Buy
163,899
+6,081
+4% +$2.04M 0.46% 44
2020
Q3
$50.1M Sell
157,818
-37,523
-19% -$11.5M 0.47% 40
2020
Q2
$57.6M Sell
195,341
-26,316
-12% -$7.54M 0.61% 32
2020
Q1
$63.7M Buy
221,657
+4
+0% +$1.1K 0.71% 22
2019
Q4
$65.2M Buy
221,653
+4,647
+2% +$1.22M 0.7% 22
2019
Q3
$47.2M Buy
217,006
+43,351
+25% +$10.5M 0.62% 28
2019
Q2
$42.2M Sell
173,655
-29,677
-15% -$7.14M 0.53% 33
2019
Q1
$50.3M Sell
203,332
-8,966
-4% -$2.29M 0.64% 26
2018
Q4
$52.9M Buy
212,298
+66,712
+46% +$17.6M 0.81% 20
2018
Q3
$38.7M Sell
145,586
-21,897
-13% -$5.7M 0.51% 35
2018
Q2
$41.1M Buy
167,483
+19,272
+13% +$4.63M 0.65% 25
2018
Q1
$31.7M Buy
148,211
+3,957
+3% +$904K 0.54% 32
2017
Q4
$31.8M Sell
144,254
-52,526
-27% -$11.1M 0.55% 35
2017
Q3
$38.5M Sell
196,780
-4,392
-2% -$848K 0.67% 23
2017
Q2
$37.3M Buy
201,172
+32,800
+19% +$5.75M 0.7% 22
2017
Q1
$27.6M Buy
168,372
+21,943
+15% +$3.59M 0.53% 32
2016
Q4
$23.4M Buy
146,429
+49,650
+51% +$7.42M 0.54% 44
2016
Q3
$13.5M Sell
96,779
-37,996
-28% -$5.32M 0.33% 77
2016
Q2
$19M Buy
134,775
+27,667
+26% +$3.69M 0.49% 50
2016
Q1
$13.7M Sell
107,108
-14,454
-12% -$1.71M 0.34% 75
2015
Q4
$14.3M Buy
121,562
+19,829
+19% +$2.32M 0.38% 64
2015
Q3
$11.8M Buy
101,733
+1,199
+1% +$144K 0.29% 105
2015
Q2
$12.3M Sell
100,534
-7,747
-7% -$916K 0.26% 108
2015
Q1
$12.8M Buy
108,281
+8,044
+8% +$893K 0.26% 108
2014
Q4
$10.1M Buy
+100,237
New +$9.5M 0.21% 140

Other funds holding UNH

Candriam SCA's UNH Position: Q2 2026 in Review

Candriam SCA increased its UnitedHealth (UNH) stake by 33% in Q2 2026, buying an estimated $28.3M and bringing the position to 309,295 shares worth $128M. The position accounts for 0.58% of the portfolio, ranked #34.

Candriam SCA first reported a position in UNH in Q4 2014 and has held it in 47 quarters since. The position peaked at $289M in Q3 2024. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Candriam SCA held 309,295 shares of UnitedHealth worth $128M as of Q2 2026.
  • Candriam SCA bought 76,456 UnitedHealth shares in Q2 2026, an estimated $28.3M.
  • UnitedHealth made up 0.58% of Candriam SCA's portfolio in Q2 2026, its #34 holding.
  • Candriam SCA first reported a position in UnitedHealth in Q4 2014 and has held it in 47 quarters since.
  • Candriam SCA's UnitedHealth position peaked at $289M in Q3 2024.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.